Cutting edge: Persistence of increased mast cell numbers in tissues links dermatitis to enhanced airway disease in a mouse model of atopy

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 531-535

  Hershko, Alon Y ^a,b   Charles, Nicolas ^a   Olivera, Ana ^a   Alvarez Errico, Damiana ^a   Rivera, Juan ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b MEIR MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4; OVALBUMIN; OXAZOLONE;

ADVERSE OUTCOME; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPY; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG SENSITIZATION; FLOW CYTOMETRY; HISTOPATHOLOGY; MAST CELL; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; SKIN ALLERGY;

ANIMALS; BRONCHIAL HYPERREACTIVITY; CELL COUNT; CHRONIC DISEASE; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; OXAZOLONE; RESPIRATORY HYPERSENSITIVITY; TISSUE DISTRIBUTION;

EID: 84856002592     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102703     Document Type: Article

References (19)

1. Gold, M. S., and A. S. Kemp. 2005. Atopic disease in childhood. Med. J. Aust. 182: 298-304.
2. Spergel, J. M., and A. S. Paller. 2003. Atopic dermatitis and the atopic march. J. Allergy Clin. Immunol. 112(6, Suppl.): S118-S127. (Pubitemid 37550028)
3. Galli, E., S. Gianni, G. Auricchio, E. Brunetti, G. Mancino, and P. Rossi. 2007. Atopic dermatitis and asthma. Allergy Asthma Proc. 28: 540-543.
4. Lowe, A. J., J. B. Carlin, C. M. Bennett, C. S. Hosking, M. J. Abramson, D. J. Hill, and S. C. Dharmage. 2008. Do boys do the atopic march while girls dawdle? J. Allergy Clin. Immunol. 121: 1190-1195.
5. Spergel, J. M. 2005. Atopic march: link to upper airways. Curr. Opin. Allergy Clin. Immunol. 5: 17-21. (Pubitemid 40175491)
6. Asher, M. I., S. Montefort, B. Björkstén, C. K. Lai, D. P. Strachan, S. K. Weiland, and H. Williams; ISAAC Phase Three Study Group. 2006. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368: 733-743. (Pubitemid 44279052)
7. Burgess, J. A., A. J. Lowe, M. C. Matheson, G. Varigos, M. J. Abramson, and S. C. Dharmage. 2009. Does eczema lead to asthma? J. Asthma 46: 429-436.
8. Strid, J., J. Hourihane, I. Kimber, R. Callard, and S. Strobel. 2004. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur. J. Immunol. 34: 2100-2109. (Pubitemid 39256091)
9. Spergel, J. M., E. Mizoguchi, J. P. Brewer, T. R. Martin, A. K. Bhan, and R. S. Geha. 1998. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 101: 1614-1622. (Pubitemid 28198490)
10. Charles, N., W. T. Watford, H. L. Ramos, L. Hellman, H. C. Oettgen, G. Gomez, J. J. Ryan, J. J. O'Shea, and J. Rivera. 2009. Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity 30: 533-543.
11. Olivera, A., C. Eisner, Y. Kitamura, S. Dillahunt, L. Allende, G. Tuymetova, W. Watford, F. Meylan, S. C. Diesner, L. Li, et al. 2010. Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J. Clin. Invest. 120: 1429-1440.
12. Parravicini, V., M. Gadina, M. Kovarova, S. Odom, C. Gonzalez-Espinosa, Y. Furumoto, S. Saitoh, L. E. Samelson, J. J. O'Shea, and J. Rivera. 2002. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 3: 741-748.
13. Razin, E., J. N. Ihle, D. Seldin, J. M. Mencia-Huerta, H. R. Katz, P. A. LeBlanc, A. Hein, J. P. Caulfield, K. F. Austen, and R. L. Stevens. 1984. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J. Immunol. 132: 1479-1486. (Pubitemid 14156069)
14. Williams, C. M., and S. J. Galli. 2000. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192: 455-462. (Pubitemid 30629171)
15. Hershko, A. Y., R. Suzuki, N. Charles, D. Alvarez-Errico, J. L. Sargent, A. Laurence, and J. Rivera. 2011. Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis. Immunity 35: 562-571.
16. Mitchell, E. B., J. Crow, G. Williams, and T. A. Platts-Mills. 1986. Increase in skin mast cells following chronic house dust mite exposure. Br. J. Dermatol. 114: 65-73. (Pubitemid 16128763)
17. Charles, N., D. Hardwick, E. Daugas, G. G. Illei, and J. Rivera. 2010. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat. Med. 16: 701-707.
18. Hahn, E. L., and L. B. Bacharier. 2005. The atopic march: the pattern of allergic disease development in childhood. Immunol. Allergy Clin. North Am. 25: 231-246, v. (Pubitemid 40692707)
19. North, M. L., and A. K. Ellis. 2011. The role of epigenetics in the developmental origins of allergic disease. Ann. Allergy Asthma Immunol. 106: 355-361, quiz 362.